ObermillerL.E., TzamaloukasA.H., LeymonP., AvasthiP.S.Intravenous vancomycin as initial treatment for gram positive peritonitis in patients on chronic peritoneal dialysis.Clin Nephrol1985; 24: 256–60.
3.
WallaceR.W., SwensonJ.M., SilcoxV.A., BullenT.G.Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.J Infect Dis1985; 152: 400–14.
HolmesC.J., LewisS.L., KubeyW.Y., Van EppsD.E.Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis.Am J Kidney Dis1990; 15: 258–64.
6.
LewisS.L., NorrisP.J., HolmesC.J.Phenotypic characterization of monocytes and macrophages from CAPD patients.ASAIO Trans1990; 36: M575–7.
7.
LewisS.L., BonnerP.N., CooperC.L., HolmesC.J.Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.J Clin Lab Immunol1992; 37: 3–19.
8.
WallaceP.J., SwensonJ.M., SilcoxV.A.Spectrum of disease due to rapidly growing mycobacteria.Rev Infect Dis1983; 5: 657–79.
9.
FoxL., MurataG.H., TzamaloukasA.H.Metabolic differences between persistent and routine peritonitis in continuous ambulatory peritoneal dialysis. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 346–50.
10.
SandersW.E., HorowitzE.A.Other mycobacterial species. In: MandelG.L., DouglasR.G., BennettJ.E., eds. Principles and practice of infectious diseases. 3rd ed.New York: Churchill Livingstone;1990: 1914–26.